2009

1. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome

   Leukemia, Vol. 23, Núm. 4, pp. 664-672

2. Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response

   Leukemia Research, Vol. 33, Núm. 1, pp. 170-173

3. Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors

   Leukemia, Vol. 23, Núm. 8, pp. 1515-1527